Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 14 Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products Authors Jakab J , Miki B, Miki S, Jurani B, osi V, Schwarz D, Vev A Received 10 September 2020 Accepted for publication 9 December 2020 Published 8 January 2021 Volume 2021:14 Pages 6783 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof
Interestingly, transient type I IFN gene expression in peripheral blood is a suggested risk factor preceding autoantibody seroconversion and autoimmunity in children with a genetic predisposition to T1D, though not all children progress to the disease (116, 117)
We further explore whether microbiome-targeted strategies, including probiotics, prebiotics, and postbiotics, may modulate or enhance these effects
gastric-derived pentadecapeptide pharmacology
